← Back to Search

Treatment for Atrial Fibrillation

N/A
Waitlist Available
Led By Dhanunjaya Lakkireddy, MD
Research Sponsored by Abbott Medical Devices
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through 24 months
Awards & highlights

Summary

This is a prospective, multicenter, observational study intended to characterize real-world outcomes on the commercially available Amulet device in the United States. Over 600 subjects have been enrolled at 16 US clinical sites. Subjects will be followed through 24 months in accordance with each site's standard care practices.

Eligible Conditions
  • Atrial Fibrillation
  • Stroke
  • Bleeding

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Composite endpoint: Death or complications
Composite endpoint: Ischemic stroke or systemic embolism
Device closure, defined as residual jet around the device ≤ 3mm

Find a Location

Who is running the clinical trial?

Abbott Medical DevicesLead Sponsor
647 Previous Clinical Trials
407,924 Total Patients Enrolled
76 Trials studying Atrial Fibrillation
31,430 Patients Enrolled for Atrial Fibrillation
Dhanunjaya Lakkireddy, MDPrincipal InvestigatorKansas City Cardiac Arrhythmia Research Foundation
29 Previous Clinical Trials
9,050 Total Patients Enrolled
15 Trials studying Atrial Fibrillation
4,702 Patients Enrolled for Atrial Fibrillation
~407 spots leftby Jun 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top